Our immunohistochemical analysis of the CCL19 and CCL21-ligands of CCR7 [22,23,24,25,26,27] demonstrated that the lymphoma cells expressed CCL19, but that CCL21 expression was low in the malignant cells. This evidence concerns the gene CCL21 and lymphoma.